{"id":7072,"date":"2026-01-24T10:09:25","date_gmt":"2026-01-24T02:09:25","guid":{"rendered":"https:\/\/qualia-bio.com\/blog\/animal-bsl-3-laboratories-for-veterinary-and-infectious-disease-research-in-the-pharmaceutical-industry\/"},"modified":"2026-01-24T10:09:26","modified_gmt":"2026-01-24T02:09:26","slug":"animal-bsl-3-laboratories-for-veterinary-and-infectious-disease-research-in-the-pharmaceutical-industry","status":"publish","type":"post","link":"https:\/\/qualia-bio.com\/tr\/blog\/animal-bsl-3-laboratories-for-veterinary-and-infectious-disease-research-in-the-pharmaceutical-industry\/","title":{"rendered":"\u0130la\u00e7 Sekt\u00f6r\u00fcnde Veterinerlik ve Bula\u015f\u0131c\u0131 Hastal\u0131k Ara\u015ft\u0131rmalar\u0131 i\u00e7in Hayvan BSL-3 Laboratuvarlar\u0131"},"content":{"rendered":"<p>Bir Hayvan Biyog\u00fcvenlik Seviyesi 3 (ABSL-3) laboratuvar\u0131 geli\u015ftirmek, herhangi bir farmas\u00f6tik kurulu\u015f i\u00e7in muazzam bir stratejik karard\u0131r. Karma\u015f\u0131kl\u0131k, g\u00fcvenli bir kutu in\u015fa etmenin \u00e7ok \u00f6tesine uzan\u0131r; \u00f6zel m\u00fchendislik, titiz operasyonel protokoller ve bir g\u00fcvenlik k\u00fclt\u00fcr\u00fcn\u00fcn bir ara\u015ft\u0131rma program\u0131n\u0131n \u00f6z\u00fcne entegre edilmesini i\u00e7erir. Tasar\u0131m, ortak se\u00e7imi veya uyumluluk y\u00f6netimindeki yanl\u0131\u015f ad\u0131mlar, feci g\u00fcvenlik hatalar\u0131na, proje gecikmelerine ve s\u00fcrd\u00fcr\u00fclemez mali y\u00fcklere yol a\u00e7abilir.<\/p>\n<p>Zoonotik hastal\u0131klar\u0131n h\u0131zlanan tehdit ortam\u0131 ve a\u015f\u0131lar ve terap\u00f6tikler i\u00e7in in vivo etkinlik verilerine duyulan kritik ihtiya\u00e7, ABSL-3 yetene\u011fini ciddi bula\u015f\u0131c\u0131 hastal\u0131k Ar-Ge'si i\u00e7in tart\u0131\u015f\u0131lmaz k\u0131lmaktad\u0131r. Bu makale, ABSL-3 stratejilerini de\u011ferlendiren farmas\u00f6tik liderleri i\u00e7in sermaye yat\u0131r\u0131m\u0131ndan operasyonel entegrasyona kadar temel hususlar\u0131n karar odakl\u0131 bir analizini sunmaktad\u0131r.<\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"keydesignsafetyfeaturesofabsl3pharmaceuticallabs\">ABSL-3 \u0130la\u00e7 Laboratuvarlar\u0131n\u0131n Temel Tasar\u0131m ve G\u00fcvenlik \u00d6zellikleri<\/h2>\n<h3 id=\"thefoundationofcontainmentairflowandaccess\">Muhafazan\u0131n Temeli: Hava Ak\u0131\u015f\u0131 ve Eri\u015fim<\/h3>\n<p>Bir ABSL-3 tesisinde mutlak \u00f6ncelik muhafaza b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn korunmas\u0131d\u0131r. Bu da \u00e7ok katmanl\u0131 bir m\u00fchendislik yakla\u015f\u0131m\u0131yla sa\u011flan\u0131r. Havan\u0131n \u201ctemiz\u201d koridorlardan laboratuvar alan\u0131na akmas\u0131n\u0131 sa\u011flayan bir negatif bas\u0131n\u00e7 kaskad\u0131 arac\u0131l\u0131\u011f\u0131yla zorunlu bir i\u00e7e do\u011fru y\u00f6nl\u00fc hava ak\u0131\u015f\u0131 sa\u011flan\u0131r. T\u00fcm egzoz havas\u0131 tahliye edilmeden \u00f6nce HEPA filtrasyonundan ge\u00e7er. Eri\u015fim, ayn\u0131 anda kap\u0131 a\u00e7\u0131lmas\u0131n\u0131 \u00f6nleyen ve fiziksel ve prosed\u00fcrel bir hava kilidi g\u00f6revi g\u00f6ren kilitli giri\u015fler arac\u0131l\u0131\u011f\u0131yla s\u0131k\u0131 bir \u015fekilde kontrol edilir. Alan dekontaminasyonuna izin vermek i\u00e7in t\u00fcm yap\u0131 m\u00fch\u00fcrlenmelidir, bu da in\u015faat malzemelerini ve y\u00f6ntemlerini temelden \u015fekillendiren bir gerekliliktir.<\/p>\n<h3 id=\"specializedadaptationsforanimalhousing\">Hayvan Bar\u0131naklar\u0131 i\u00e7in \u00d6zel Uyarlamalar<\/h3>\n<p>Canl\u0131, enfekte hayvanlar\u0131n getirilmesi, muhafaza zorlu\u011funu d\u00f6n\u00fc\u015ft\u00fcr\u00fcr. Standart BSL-3 uygulamalar\u0131 yetersizdir. Birincil adaptasyon, en yayg\u0131n olarak Bireysel Havaland\u0131rmal\u0131 Kafes (IVC) sistemleri olmak \u00fczere \u00f6zel kafeslerin kullan\u0131lmas\u0131d\u0131r. Bunlar do\u011frudan her kafese HEPA filtreli hava sa\u011flayarak patojenleri kayna\u011f\u0131nda tutar ve hayvan kolonilerinin \u00fcretti\u011fi \u00f6nemli \u0131s\u0131 ve nem y\u00fck\u00fcn\u00fc y\u00f6netir. Birincil laboratuvar bariyeri i\u00e7indeki bu ikincil muhafaza katman\u0131, g\u00fcnl\u00fck bak\u0131m s\u0131ras\u0131nda personeli korumak ve hayvan refah\u0131n\u0131 ve \u00e7al\u0131\u015fman\u0131n tekrarlanabilirli\u011fini sa\u011flamak i\u00e7in kritik \u00f6neme sahiptir.<\/p>\n<h3 id=\"integratedsafetyanddecontaminationsystems\">Entegre G\u00fcvenlik ve Dekontaminasyon Sistemleri<\/h3>\n<p>G\u00fcvenlik, her operasyonel temas noktas\u0131nda tasarlanm\u0131\u015ft\u0131r. T\u00fcm aerosol \u00fcreten prosed\u00fcrler -nekropsi, doku homojenizasyonu, vorteksleme- bir S\u0131n\u0131f II Biyog\u00fcvenlik Kabini i\u00e7inde ger\u00e7ekle\u015ftirilmelidir. Acil durum g\u00f6z y\u0131kama istasyonlar\u0131 ve eller serbest lavabolar\u0131 an\u0131nda m\u00fcdahale i\u00e7in stratejik olarak yerle\u015ftirilmi\u015ftir. En \u00f6nemlisi, at\u0131k y\u00f6netimi kapal\u0131 bir s\u00fcre\u00e7tir; dahili ge\u00e7i\u015fli otoklavlar, bertaraf i\u00e7in \u00e7\u0131kar\u0131lmadan \u00f6nce laboratuvar s\u0131n\u0131rlar\u0131 i\u00e7indeki t\u00fcm biyolojik tehlikeli at\u0131klar\u0131n sterilize edilmesini sa\u011flar. Bu kapal\u0131 d\u00f6ng\u00fc sistemi, patojen ka\u00e7\u0131\u015f\u0131 i\u00e7in \u00f6nemli bir potansiyel vekt\u00f6r\u00fc ortadan kald\u0131r\u0131r.<\/p>\n<table>\n<thead>\n<tr>\n<th>\u00d6zellik Kategorisi<\/th>\n<th>Temel \u00d6zellikler \/ Ekipman<\/th>\n<th>Operasyonel Ama\u00e7<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Eri\u015fim Kontrol\u00fc<\/td>\n<td>Birbirine kenetlenmi\u015f giri\u015fler<\/td>\n<td>S\u0131k\u0131 personel giri\u015f kontrol\u00fc<\/td>\n<\/tr>\n<tr>\n<td>Hava Ak\u0131\u015f\u0131 ve Filtrasyon<\/td>\n<td>Negatif bas\u0131n\u00e7, HEPA egzoz<\/td>\n<td>\u0130\u00e7e d\u00f6n\u00fck hava muhafazas\u0131<\/td>\n<\/tr>\n<tr>\n<td>Hayvan Bar\u0131naklar\u0131<\/td>\n<td>Bireysel Havaland\u0131rmal\u0131 Kafes (IVC) sistemleri<\/td>\n<td>Patojen muhafazas\u0131 ve \u0131s\u0131 y\u00f6netimi<\/td>\n<\/tr>\n<tr>\n<td>Dekontaminasyon<\/td>\n<td>Ge\u00e7i\u015fli otoklavlar<\/td>\n<td>\u00c7\u0131karmadan \u00f6nce at\u0131k sterilizasyonu<\/td>\n<\/tr>\n<tr>\n<td>Acil Durum G\u00fcvenli\u011fi<\/td>\n<td>Eller serbest lavabolar, g\u00f6z y\u0131kama istasyonlar\u0131<\/td>\n<td>An\u0131nda maruz kalma yan\u0131t\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Kaynak: <a href=\"https:\/\/www.cdc.gov\/labs\/pdf\/SF__19_308133-A_BMBL6_00-BOOK-WEB-final-3.pdf\">Mikrobiyolojik ve Biyomedikal Laboratuvarlarda Biyog\u00fcvenlik, 6. Bask\u0131 (BMBL6)<\/a>. BMBL, BSL-3\/ABSL-3 tesis tasar\u0131m\u0131 i\u00e7in temel gereklilikleri sa\u011flayarak kontroll\u00fc eri\u015fim, y\u00f6nl\u00fc hava ak\u0131\u015f\u0131, HEPA filtreleme ve bula\u015f\u0131c\u0131 ajanlar\u0131n ta\u015f\u0131nmas\u0131 i\u00e7in \u00f6zel g\u00fcvenlik ekipmanlar\u0131 gibi \u00f6zellikleri zorunlu k\u0131lar.<\/em><\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"costanalysisinvestmentoperationalexpensesforabsl3labs\">Maliyet Analizi: ABSL-3 Laboratuvarlar\u0131 i\u00e7in Yat\u0131r\u0131m ve \u0130\u015fletme Giderleri<\/h2>\n<h3 id=\"understandingthecapitalbarrier\">Sermaye Engelini Anlamak<\/h3>\n<p>S\u0131f\u0131rdan kurulan bir ABSL-3 tesisi i\u00e7in ilk sermaye yat\u0131r\u0131m\u0131 olduk\u00e7a y\u00fcksektir ve genellikle on milyonlarca dolara ula\u015f\u0131r. Bu y\u00fcksek maliyet, pazarl\u0131k konusu olmayan altyap\u0131dan kaynaklanmaktad\u0131r: s\u0131zd\u0131rmaz yap\u0131, yedekli HEPA filtrasyonlu karma\u015f\u0131k HVAC sistemleri, otomatik kontrol sistemleri ve \u00f6zel y\u00fczeyler. Bu finansal engel, b\u00fcy\u00fck ila\u00e7 firmalar\u0131n\u0131, devlet kurumlar\u0131n\u0131 ve iyi finanse edilen kar amac\u0131 g\u00fctmeyen kurulu\u015flar\u0131 tercih ederek pazar\u0131 temelden \u015fekillendirmektedir. \u00c7o\u011fu kurulu\u015f i\u00e7in yap-sat\u0131n al analizi hemen d\u0131\u015f kaynak kullan\u0131m\u0131 veya ortak kullan\u0131m modellerine i\u015faret etmektedir.<\/p>\n<h3 id=\"therealityofrecurringoperationalcosts\">Yinelenen Operasyonel Maliyetler Ger\u00e7e\u011fi<\/h3>\n<p>Sermaye harcamalar\u0131 sadece ba\u015flang\u0131\u00e7t\u0131r. Y\u0131ll\u0131k i\u015fletme ve bak\u0131m maliyetleri genellikle ilk in\u015fa maliyetinin 10-15%'si olarak tahmin edilmektedir. Buna HEPA filtre de\u011fi\u015fimi, titiz sertifikasyon ve do\u011frulama d\u00f6ng\u00fcleri, negatif bas\u0131nc\u0131n korunmas\u0131 i\u00e7in kamu hizmeti t\u00fcketimi ve BSL-3 s\u0131n\u0131f\u0131 sarf malzemeleri ve KKD'nin y\u00fcksek maliyeti dahildir. Yayg\u0131n bir g\u00f6z ard\u0131, \u00f6nleyici bak\u0131m maliyetini hafife almakt\u0131r; a\u015f\u0131nd\u0131r\u0131c\u0131 dezenfektanlar\u0131n kullan\u0131lmas\u0131 y\u00fczeyleri ve ekipman\u0131 bozabilir, bu da maliyetli tesis duru\u015f s\u00fcrelerine ve onar\u0131mlara yol a\u00e7abilir. Malzeme uyumlulu\u011fu onaylanm\u0131\u015f EPA tescilli dezenfektanlar\u0131n stratejik se\u00e7imi basit ama kritik bir maliyet kontrol \u00f6nlemidir.<\/p>\n<table>\n<thead>\n<tr>\n<th>Maliyet Bile\u015feni<\/th>\n<th>Tipik Aral\u0131k \/ \u015eekil<\/th>\n<th>Finansal Etki<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Sermaye Yat\u0131r\u0131m\u0131<\/td>\n<td>\u00d6nemli, multi-milyon ABD Dolar\u0131<\/td>\n<td>Y\u00fcksek giri\u015f engeli<\/td>\n<\/tr>\n<tr>\n<td>Y\u0131ll\u0131k Bak\u0131m<\/td>\n<td>10-15% yap\u0131 maliyeti<\/td>\n<td>Ba\u015fl\u0131ca yinelenen operasyonel giderler<\/td>\n<\/tr>\n<tr>\n<td>Birincil Kurulu\u015flar<\/td>\n<td>B\u00fcy\u00fck ila\u00e7 firmalar\u0131, devlet, kar amac\u0131 g\u00fctmeyen kurulu\u015flar<\/td>\n<td>Y\u00fcksek sermaye maliyetlerini absorbe edebilir<\/td>\n<\/tr>\n<tr>\n<td>Daha K\u00fc\u00e7\u00fck Kurulu\u015flar<\/td>\n<td>D\u0131\u015f kaynak modelleri<\/td>\n<td>Sermaye yat\u0131r\u0131m\u0131 y\u00fck\u00fcnden ka\u00e7\u0131n\u0131r<\/td>\n<\/tr>\n<tr>\n<td>Stratejik Maliyet Kontrol\u00fc<\/td>\n<td>EPA tescilli dezenfektan se\u00e7imi<\/td>\n<td>Korozif altyap\u0131 hasar\u0131n\u0131 \u00f6nler<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Kaynak: Teknik dok\u00fcmantasyon ve end\u00fcstri spesifikasyonlar\u0131.<\/em><\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"absl3vsbsl3criticaldifferencesforanimalresearch\">ABSL-3 vs. BSL-3: Hayvan Ara\u015ft\u0131rmalar\u0131 i\u00e7in Kritik Farklar<\/h2>\n<h3 id=\"thecoredistinctiondynamicbiologicalsystems\">\u00c7ekirdek Ayr\u0131m\u0131: Dinamik Biyolojik Sistemler<\/h3>\n<p>Hem BSL-3 hem de ABSL-3 laboratuvarlar\u0131 temel muhafaza ilkelerini payla\u015f\u0131rken, enfekte hayvanlar\u0131n varl\u0131\u011f\u0131 standart mikrobiyoloji laboratuvarlar\u0131n\u0131n \u00fcstesinden gelmek i\u00e7in tasarlanmad\u0131\u011f\u0131 bir karma\u015f\u0131kl\u0131k katman\u0131 ortaya \u00e7\u0131kar\u0131r. Bir BSL-3 laboratuvar\u0131 kontroll\u00fc konteynerlerdeki statik numuneleri y\u00f6netir. ABSL-3 laboratuvar\u0131 ise \u0131s\u0131, alerjenler, \u00f6ng\u00f6r\u00fclemeyen davran\u0131\u015flar ve bol miktarda at\u0131k \u00fcreten dinamik, canl\u0131 sistemleri y\u00f6netir. Birincil tehlike yaln\u0131zca aerosol haline gelmi\u015f patojenlerden \u0131s\u0131r\u0131k, \u00e7izik ve kontamine yatak ve d\u0131\u015fk\u0131 ile do\u011frudan temas\u0131 i\u00e7erecek \u015fekilde de\u011fi\u015fir.<\/p>\n<h3 id=\"specializedinfrastructureandprotocols\">\u00d6zel Altyap\u0131 ve Protokoller<\/h3>\n<p>Bu ayr\u0131m \u00f6zel bir altyap\u0131y\u0131 zorunlu k\u0131lmaktad\u0131r. ABSL-3, biyog\u00fcvenlik kabinlerinin \u00f6tesinde, IVC sistemleri veya sert izolat\u00f6rler gibi birincil muhafazal\u0131 hayvan bar\u0131na\u011f\u0131 gerektirir. Protokoller hayvanlar\u0131n kabul\u00fc, al\u0131\u015ft\u0131rma, ta\u015f\u0131ma, klinik g\u00f6zlem, anestezi ve nekropsiyi kapsayacak \u015fekilde geni\u015fler. At\u0131k y\u00f6netimi \u00f6nemli \u00f6l\u00e7\u00fcde \u00f6l\u00e7eklenir ve karkaslar ve kirli yatak tak\u0131mlar\u0131 i\u00e7in \u00f6zel dekontaminasyon yollar\u0131 gerektirir. Veteriner bak\u0131m program\u0131, hem hayvan t\u0131bb\u0131ndan hem de biyog\u00fcvenlikten anlayan e\u011fitimli personel gerektiren muhafaza \u00e7evresi i\u00e7inde \u00e7al\u0131\u015fmal\u0131d\u0131r.<\/p>\n<h3 id=\"theflexibilityofriskbasedadaptations\">Risk Tabanl\u0131 Uyarlamalar\u0131n Esnekli\u011fi<\/h3>\n<p>Kritik bir operasyonel i\u00e7g\u00f6r\u00fc, muhafaza seviyesinin her zaman ikili, tesis \u00e7ap\u0131nda bir tan\u0131mlama olmad\u0131\u011f\u0131d\u0131r. G\u00f6reve ba\u011fl\u0131 olabilir. D\u00fc\u015f\u00fck konsantrasyonda bilinen bir ajan\u0131n kullan\u0131ld\u0131\u011f\u0131 baz\u0131 d\u00fc\u015f\u00fck riskli prosed\u00fcrler i\u00e7in risk de\u011ferlendirmesi, \u00f6zel bir alanda geli\u015fmi\u015f BSL-2 uygulamalar\u0131n\u0131 (\u201cBSL-2+\u201d) hakl\u0131 g\u00f6sterebilir. Bu yakla\u015f\u0131m, Avrupa Konseyi taraf\u0131ndan onaylanm\u0131\u015ft\u0131r. <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240011311\">DS\u00d6 Laboratuvar Biyog\u00fcvenlik El Kitab\u0131, D\u00f6rd\u00fcnc\u00fc Bask\u0131<\/a>, y\u00fcksek muhafaza kaynaklar\u0131n\u0131n kullan\u0131m\u0131n\u0131 optimize eder. Daha d\u00fc\u015f\u00fck riskli i\u015flerin de\u011ferli ABSL-3 alan\u0131n\u0131 i\u015fgal etmeden devam etmesine olanak tan\u0131r, bu da operasyonel \u00e7evikli\u011fi ve maliyet verimlili\u011fini art\u0131rmak i\u00e7in \u00f6nemli bir stratejidir.<\/p>\n<table>\n<thead>\n<tr>\n<th>Aspect<\/th>\n<th>BSL-3 Laboratuvar\u0131<\/th>\n<th>ABSL-3 Laboratuvar\u0131<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Birincil Odak<\/td>\n<td>Mikrobiyolojik ajan kullan\u0131m\u0131<\/td>\n<td>Enfekte canl\u0131 hayvan bar\u0131naklar\u0131<\/td>\n<\/tr>\n<tr>\n<td>Temel Zorluklar<\/td>\n<td>Aerosol muhafazas\u0131<\/td>\n<td>Hayvan kaynakl\u0131 tehlikeler (\u0131s\u0131, alerjenler)<\/td>\n<\/tr>\n<tr>\n<td>\u00c7ekirdek Ekipman<\/td>\n<td>Biyog\u00fcvenlik kabinleri (BSC'ler)<\/td>\n<td>BSC'ler + \u00f6zel kafesleme (\u00f6rn. IVC)<\/td>\n<\/tr>\n<tr>\n<td>Protokol Vurgusu<\/td>\n<td>\u00d6rnek i\u015fleme g\u00fcvenli\u011fi<\/td>\n<td>Hayvan ta\u015f\u0131ma, nekropsi, at\u0131k y\u00f6netimi<\/td>\n<\/tr>\n<tr>\n<td>Operasyonel Esneklik<\/td>\n<td>Sabit muhafaza seviyesi<\/td>\n<td>Risk temelli uyarlamalar m\u00fcmk\u00fcnd\u00fcr (\u00f6rn. BSL-2+)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Kaynak: <a href=\"https:\/\/www.cdc.gov\/labs\/pdf\/SF__19_308133-A_BMBL6_00-BOOK-WEB-final-3.pdf\">Mikrobiyolojik ve Biyomedikal Laboratuvarlarda Biyog\u00fcvenlik, 6. Bask\u0131 (BMBL6)<\/a>. BMBL, standart BSL-3 gerekliliklerinin \u00f6tesinde \u00f6zel bar\u0131nma, yeti\u015ftirme ve veteriner bak\u0131m uygulamalar\u0131 da dahil olmak \u00fczere Hayvan Biyog\u00fcvenlik Seviyesi 3 (ABSL-3) i\u00e7in geli\u015ftirilmi\u015f gereklilikleri belirgin bir \u015fekilde \u00f6zetlemektedir.<\/em><\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"selectingtherightabsl3labforyourresearchprogram\">Ara\u015ft\u0131rma Program\u0131n\u0131z i\u00e7in Do\u011fru ABSL-3 Laboratuvar\u0131n\u0131 Se\u00e7me<\/h2>\n<h3 id=\"matchingcapabilitiestoprogramrequirements\">Yeteneklerin Program Gereksinimleriyle E\u015fle\u015ftirilmesi<\/h3>\n<p>Se\u00e7im, ara\u015ft\u0131rma program\u0131n\u0131z ile tesisin teknik kabiliyetleri aras\u0131nda hassas bir uyumun sa\u011flanmas\u0131yla ba\u015flar. Temel kriterler aras\u0131nda t\u00fcre \u00f6zg\u00fc bar\u0131nd\u0131rma ve i\u015fleme uzmanl\u0131\u011f\u0131, mevcut biyog\u00fcvenlik kabinlerinin t\u00fcrleri ve miktar\u0131 ve hayvan odalar\u0131n\u0131n ve ekipmanlar\u0131n\u0131n dekontaminasyonu i\u00e7in onaylanm\u0131\u015f y\u00f6ntemler (\u00f6rne\u011fin, buharla\u015ft\u0131r\u0131lm\u0131\u015f hidrojen peroksit d\u00f6ng\u00fcleri) yer al\u0131r. Tesis, spesifik hayvan modelinizi ve enfeksiyon yolunuzu desteklemelidir. Bu ayr\u0131nt\u0131lar\u0131n g\u00f6zden ka\u00e7\u0131r\u0131lmas\u0131, sertifikas\u0131 ne olursa olsun bir tesisi uygunsuz hale getirebilir.<\/p>\n<h3 id=\"evaluatingaccreditationandmanagementsystems\">Akreditasyon ve Y\u00f6netim Sistemlerinin De\u011ferlendirilmesi<\/h3>\n<p>BMBL ile temel uyum asgari d\u00fczeydedir. Fark yaratan fakt\u00f6r genellikle tesisin sistematik bir biyorisk y\u00f6netimi \u00e7er\u00e7evesini benimsemesidir. A\u015fa\u011f\u0131daki gibi standartlara akreditasyon <a href=\"https:\/\/www.iso.org\/news\/ref2472.html\">ISO 35001: Laboratuvarlar ve di\u011fer ilgili kurulu\u015flar i\u00e7in biyorisk y\u00f6netimi<\/a> kontrol listesi uyumlulu\u011funun \u00f6tesine ge\u00e7en proaktif, b\u00fct\u00fcnsel bir emniyet ve g\u00fcvenlik yakla\u015f\u0131m\u0131 sergilemektedir. Risk de\u011ferlendirmesi, s\u00fcrekli iyile\u015ftirme ve yetkinlik g\u00fcvencesi i\u00e7in bu yap\u0131land\u0131r\u0131lm\u0131\u015f sistem, k\u00fcresel sa\u011fl\u0131k kurulu\u015flar\u0131ndan finansman sa\u011flamak ve uluslararas\u0131 i\u015fbirliklerinde g\u00fcven olu\u015fturmak i\u00e7in giderek daha fazla \u00f6n ko\u015ful haline gelmektedir.<\/p>\n<h3 id=\"auditingtheintegratedsupplychain\">Entegre Tedarik Zincirinin Denetlenmesi<\/h3>\n<p>Muhafaza b\u00fct\u00fcnl\u00fc\u011f\u00fc ancak tedarik zincirindeki en zay\u0131f halka kadar g\u00fc\u00e7l\u00fcd\u00fcr. Tesis, m\u00fch\u00fcrl\u00fc santrif\u00fcj rotorlar\u0131 ve ta\u015f\u0131ma ortam\u0131ndan uygun ki\u015fisel koruyucu ekipmana kadar t\u00fcm BSL-3 dereceli sarf malzemeleri i\u00e7in do\u011frulanm\u0131\u015f kaynaklara sahip olmal\u0131d\u0131r. Bir denetim, muhafaza b\u00f6lgesine giren her malzemenin dekontaminasyon prosed\u00fcrleriyle uyumlu oldu\u011funu ve kapal\u0131 ortam\u0131 tehlikeye atmad\u0131\u011f\u0131n\u0131 do\u011frulamal\u0131d\u0131r. K\u0131r\u0131lgan veya \u015feffaf olmayan bir tedarik zincirine sahip bir ortak, kabul edilemez operasyonel riskler do\u011furur.<\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"essentialoperationalprotocolsstafftrainingrequirements\">Temel Operasyonel Protokoller ve Personel E\u011fitim Gereklilikleri<\/h2>\n<h3 id=\"theprotocolmatrixgoverningdailywork\">G\u00fcnl\u00fck \u00c7al\u0131\u015fmay\u0131 Y\u00f6neten Protokol Matrisi<\/h3>\n<p>Operasyonel g\u00fcvenlik, kapsaml\u0131 bir Standart \u00c7al\u0131\u015fma Prosed\u00fcrleri (SOP'ler) setinde kodlanm\u0131\u015ft\u0131r. Bunlar her faaliyeti y\u00f6netir: KKD'nin giyilmesi ve \u00e7\u0131kar\u0131lmas\u0131, laboratuvara giri\u015f ve \u00e7\u0131k\u0131\u015f, hayvan ta\u015f\u0131ma ve zapt etme, numune toplama, at\u0131k torbalama ve otoklavlama ve d\u00f6k\u00fclmeye m\u00fcdahale. Aerosol \u00fcreten prosed\u00fcrler kesinlikle biyog\u00fcvenlik kabinleriyle s\u0131n\u0131rl\u0131d\u0131r. Santrif\u00fcjlerde s\u0131zd\u0131rmaz rotorlar veya muhafaza kaplar\u0131 kullan\u0131lmal\u0131d\u0131r. Basit bir kafes de\u011fi\u015ftirme protokol\u00fc, karma\u015f\u0131k bir nekropsi i\u00e7in oldu\u011fu kadar titizlikle tasarlanm\u0131\u015ft\u0131r. Bu prosed\u00fcrel kat\u0131l\u0131k, m\u00fchendislik kontrollerinin insan katman\u0131ndaki kar\u015f\u0131l\u0131\u011f\u0131d\u0131r.<\/p>\n<h3 id=\"foundationalandsustainedtraining\">Temel ve S\u00fcrekli E\u011fitim<\/h3>\n<p>Eri\u015fim ancak ABSL-3 ortam\u0131na \u00f6zg\u00fc kapsaml\u0131, uygulamal\u0131 e\u011fitimden sonra verilir. Bu e\u011fitim teorik biyog\u00fcvenlik ilkelerini, pratik SOP uygulamalar\u0131n\u0131, acil durum m\u00fcdahale tatbikatlar\u0131n\u0131 ve t\u00fcm g\u00fcvenlik ekipmanlar\u0131n\u0131n do\u011fru kullan\u0131m\u0131n\u0131 kapsar. En \u00f6nemlisi, e\u011fitim tek seferlik bir etkinlik de\u011fildir. Yetkinli\u011fin s\u00fcrd\u00fcr\u00fclmesi i\u00e7in zorunlu y\u0131ll\u0131k yenilemeler gereklidir. Ayr\u0131ca, resmi bir t\u0131bbi g\u00f6zetim program\u0131, tehlikeli biyolojik ajanlarla \u00e7al\u0131\u015fan personel i\u00e7in m\u00fczakere edilemez bir gereklilik olan personel sa\u011fl\u0131\u011f\u0131n\u0131 izler. Deneyimlerimize g\u00f6re, bir tesisin e\u011fitim program\u0131n\u0131n derinli\u011fi, g\u00fcvenlik k\u00fclt\u00fcr\u00fcn\u00fcn en g\u00fcvenilir g\u00f6stergesidir.<\/p>\n<h3 id=\"thestrategicimperativefortherapeuticdevelopment\">Terap\u00f6tik Geli\u015ftirme i\u00e7in Stratejik Zorunluluk<\/h3>\n<p>Bu titiz protokoller sadece idari engeller de\u011fildir. Bunlar y\u00fcksek muhafazal\u0131 in vivo ara\u015ft\u0131rmalar i\u00e7in temel kolayla\u015ft\u0131r\u0131c\u0131lard\u0131r. ABSL-3 ortam\u0131n\u0131n garantili g\u00fcvenli\u011fi olmadan, zoonotik a\u015f\u0131 adaylar\u0131 i\u00e7in challenge \u00e7al\u0131\u015fmalar\u0131 y\u00fcr\u00fctmek veya yeni antiviralleri ilgili hayvan modellerinde test etmek imkans\u0131zd\u0131r. Bu kapasite, bir \u015firketin bula\u015f\u0131c\u0131 hastal\u0131k boru hatlar\u0131n\u0131 in vitro ke\u015fiften g\u00fcvenilir klinik \u00f6ncesi kavram kan\u0131t\u0131na kadar ilerletme yetene\u011fini do\u011frudan belirler.<\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"validatingmaintainingabsl3facilitycompliance\">ABSL-3 Tesis Uyumlulu\u011funun Do\u011frulanmas\u0131 ve S\u00fcrd\u00fcr\u00fclmesi<\/h2>\n<h3 id=\"continuousperformanceverification\">S\u00fcrekli Performans Do\u011frulamas\u0131<\/h3>\n<p>Uyumluluk dinamik bir durumdur, statik bir sertifika de\u011fildir. Programlanm\u0131\u015f bir do\u011frulama faaliyetleri rejimi gerektirir. HEPA filtreler b\u00fct\u00fcnl\u00fck ve verimlilik a\u00e7\u0131s\u0131ndan y\u0131ll\u0131k olarak sertifikaland\u0131r\u0131l\u0131r. Negatif bas\u0131n\u00e7 kaskad\u0131 ve y\u00f6nl\u00fc hava ak\u0131\u015f\u0131 s\u00fcrekli olarak izlenir ve d\u00fczenli aral\u0131klarla resmi olarak do\u011frulan\u0131r. Otoklavlar ve at\u0131k su dekontaminasyon sistemleri gibi kritik dekontaminasyon ekipmanlar\u0131, sterilizasyon d\u00f6ng\u00fclerinin biyolojik g\u00f6stergelerde gerekli log azalt\u0131m\u0131n\u0131 sa\u011flad\u0131\u011f\u0131ndan emin olmak i\u00e7in titiz bir performans kalifikasyonuna tabi tutulur.<\/p>\n<h3 id=\"maintenanceasacapitalpreservationstrategy\">Sermaye Koruma Stratejisi Olarak Bak\u0131m<\/h3>\n<p>\u00d6nleyici bak\u0131m stratejik bir i\u015flevdir. Ama\u00e7, milyonlarca dolarl\u0131k sermaye yat\u0131r\u0131m\u0131n\u0131 bozulma ve ar\u0131zalardan korumakt\u0131r. Bu, sens\u00f6rlerin kalibre edilmesini, HVAC sistemindeki \u00fcfleyicilerin ve damperlerin bak\u0131m\u0131n\u0131n yap\u0131lmas\u0131n\u0131 ve kap\u0131lardaki ve ge\u00e7i\u015flerdeki contalar\u0131n incelenmesini i\u00e7erir. S\u0131k\u0131 bir bak\u0131m program\u0131na uyulmas\u0131, k\u00fc\u00e7\u00fck sorunlar\u0131n y\u0131k\u0131c\u0131 muhafaza ihlallerine veya projeyi durduran tesis duru\u015f s\u00fcrelerine d\u00f6n\u00fc\u015fmesini \u00f6nler. ISO 35001 taraf\u0131ndan zorunlu k\u0131l\u0131nan sistematik yakla\u015f\u0131m, bu bak\u0131m\u0131 reaktif bir angarya olmaktan \u00e7\u0131kar\u0131p risk y\u00f6netiminin temel bir bile\u015fenine d\u00f6n\u00fc\u015ft\u00fcr\u00fcr.<\/p>\n<table>\n<thead>\n<tr>\n<th>Do\u011frulama Faaliyeti<\/th>\n<th>Anahtar Parametre \/ Standart<\/th>\n<th>S\u0131kl\u0131k \/ Ama\u00e7<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>HEPA Filtre Sertifikasyonu<\/td>\n<td>D\u00fcr\u00fcstl\u00fck ve verimlilik<\/td>\n<td>D\u00fczenli, periyodik testler<\/td>\n<\/tr>\n<tr>\n<td>Hava Ak\u0131\u015f\u0131 Do\u011frulamas\u0131<\/td>\n<td>Negatif bas\u0131n\u00e7 kaskad\u0131<\/td>\n<td>S\u00fcrekli izleme ve do\u011frulama<\/td>\n<\/tr>\n<tr>\n<td>Ekipman Do\u011frulama<\/td>\n<td>Otoklav sterilizasyon d\u00f6ng\u00fcleri<\/td>\n<td>D\u00fczenli performans kalifikasyonu<\/td>\n<\/tr>\n<tr>\n<td>Y\u00f6netim \u00c7er\u00e7evesi<\/td>\n<td>ISO 35001 biyorisk sistemi<\/td>\n<td>Devam eden yetkinlik g\u00f6sterimi<\/td>\n<\/tr>\n<tr>\n<td>Stratejik Hedef<\/td>\n<td>Muhafaza ar\u0131zas\u0131n\u0131 \u00f6nleyin<\/td>\n<td>Sermaye yat\u0131r\u0131m\u0131n\u0131 ve \u00e7al\u0131\u015fma s\u00fcresini koruyun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Kaynak: <a href=\"https:\/\/www.iso.org\/news\/ref2472.html\">ISO 35001: Laboratuvarlar ve di\u011fer ilgili kurulu\u015flar i\u00e7in biyorisk y\u00f6netimi<\/a>. ISO 35001, muhafaza tesislerinin ve ekipmanlar\u0131n\u0131n s\u00fcrekli olarak do\u011frulanmas\u0131, bak\u0131m\u0131 ve performans\u0131n\u0131n g\u00f6zden ge\u00e7irilmesine y\u00f6nelik s\u00fcre\u00e7leri i\u00e7eren sistematik bir biyorisk y\u00f6netim sisteminin kurulmas\u0131na y\u00f6nelik bir \u00e7er\u00e7eve sunmaktad\u0131r.<\/em><\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"integratingabsl3labsintothedrugdevelopmentpipeline\">ABSL-3 Laboratuvarlar\u0131n\u0131n \u0130la\u00e7 Geli\u015ftirme Hatt\u0131na Entegre Edilmesi<\/h2>\n<h3 id=\"enablingcriticalpreclinicalmilestones\">Kritik Klinik \u00d6ncesi Kilometre Ta\u015flar\u0131n\u0131n Etkinle\u015ftirilmesi<\/h3>\n<p>ABSL-3 tesisleri izole ara\u015ft\u0131rma sahalar\u0131 de\u011fildir; biyolojik ila\u00e7lar ve antiviraller i\u00e7in geli\u015ftirme hatt\u0131ndaki entegre d\u00fc\u011f\u00fcmlerdir. In vitro deney sonu\u00e7lar\u0131ndan in vivo etkinli\u011fe ge\u00e7i\u015fi sa\u011flarlar. Bu laboratuvarlarda y\u00fcr\u00fct\u00fclen temel klinik \u00f6ncesi faaliyetler aras\u0131nda a\u015f\u0131 adaylar\u0131n\u0131n imm\u00fcnojenisite testleri, korumay\u0131 g\u00f6stermek i\u00e7in kavram kan\u0131tlama \u00e7al\u0131\u015fmalar\u0131 ve enfekte hayvan modellerinde terap\u00f6tiklerin farmakokinetik\/farmakodinamik \u00e7al\u0131\u015fmalar\u0131 yer almaktad\u0131r. Burada \u00fcretilen veriler, bir aday\u0131n GMP \u00fcretimine ve klinik deneylere ilerletilmesi karar\u0131n\u0131 riskten ar\u0131nd\u0131r\u0131r.<\/p>\n<h3 id=\"thepublicprivatepartnershipmodel\">Kamu-\u00d6zel Sekt\u00f6r Ortakl\u0131\u011f\u0131 Modeli<\/h3>\n<p>ABSL-3 \u00e7al\u0131\u015fmalar\u0131n\u0131n \u00f6l\u00e7e\u011fi ve maliyeti genellikle i\u015fbirli\u011fini gerektirmektedir. \u00d6zel Biyolojik Geli\u015ftirme Mod\u00fcl\u00fc ile Ulusal Biyo ve Tar\u0131msal Savunma Tesisi (NBAF) gibi tesislerin evrimi, resmile\u015ftirilmi\u015f bir kamu-\u00f6zel ortakl\u0131k modelini \u00f6rneklemektedir. Devlet kurumlar\u0131 temel patojen ara\u015ft\u0131rmalar\u0131 y\u00fcr\u00fctmekte ve prototip a\u015f\u0131lar geli\u015ftirmektedir; bu a\u015f\u0131lar daha sonra end\u00fcstri ortaklar\u0131 taraf\u0131ndan lisanslan\u0131p ticari \u00fcretim i\u00e7in \u00f6l\u00e7eklendirilebilmektedir. Afrika Domuz Ate\u015fi gibi tehditlere y\u00f6nelik \u00e7al\u0131\u015fmalarda g\u00f6r\u00fclebilen bu model, \u00f6zel sekt\u00f6r\u00fcn geli\u015fimi i\u00e7in kamu altyap\u0131s\u0131ndan yararlanarak temel ara\u015ft\u0131rmalar\u0131n pazara haz\u0131r kar\u015f\u0131 \u00f6nlemlere d\u00f6n\u00fc\u015ft\u00fcr\u00fclmesini h\u0131zland\u0131rmaktad\u0131r.<\/p>\n<h3 id=\"aspecializedlinkinthechain\">Zincirin Uzmanla\u015fm\u0131\u015f Bir Halkas\u0131<\/h3>\n<p>Bu y\u00fcksek muhafaza duvarlar\u0131 i\u00e7indeki \u00e7al\u0131\u015fmalar do\u011frudan a\u015fa\u011f\u0131 ak\u0131\u015fa beslenir <a href=\"https:\/\/qualia-bio.com\/tr\/\">\u00f6zel farmas\u00f6tik geli\u015ftirme ve \u00fcretim s\u00fcre\u00e7leri<\/a>. Bir ABSL-3 laboratuvar\u0131nda \u00fcretilen ara\u015ft\u0131rma \u00f6l\u00e7e\u011findeki partilerden klinik ve ticari \u00f6l\u00e7ekli \u00fcretime ge\u00e7i\u015f, bula\u015f\u0131c\u0131 hastal\u0131k \u00fcr\u00fcnleri i\u00e7in benzersiz muhafaza, safla\u015ft\u0131rma ve d\u00fczenleme yollar\u0131n\u0131 anlayan ortaklar gerektirir. Bu u\u00e7tan uca devaml\u0131l\u0131k, verimli bir \u00e7eviri i\u00e7in gereklidir.<\/p>\n\t\t<div data-elementor-type=\"widget\" data-elementor-id=\"6744\" class=\"elementor elementor-6744\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6744 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"6744\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjI1MzMiLCJ0b2dnbGUiOmZhbHNlfQ%3D%3D\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">\u015eimdi Sorgula<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<h2 id=\"choosingapartnercriteriaforabsl3laboratoryservices\">Ortak Se\u00e7imi: ABSL-3 Laboratuvar Hizmetleri i\u00e7in Kriterler<\/h2>\n<h3 id=\"assessingtechnicalandoperationalcompetency\">Teknik ve Operasyonel Yetkinli\u011fin De\u011ferlendirilmesi<\/h3>\n<p>D\u0131\u015f kaynak kullan\u0131m\u0131 s\u00f6z konusu oldu\u011funda, durum tespiti bir tesisin BSL-3 tan\u0131mlamas\u0131n\u0131n \u00e7ok \u00f6tesine uzanmal\u0131d\u0131r. Birincil de\u011ferlendirme patojen ve modele \u00f6zg\u00fc deneyimdir. Ortak, ama\u00e7lanan hayvan modelinde spesifik ajan\u0131n\u0131zla ba\u015far\u0131l\u0131 bir \u015fekilde \u00e7al\u0131\u015fmalar y\u00fcr\u00fctt\u00fc m\u00fc? Operasyonel esnekliklerini inceleyin: Kaynaklar\u0131 korumak i\u00e7in gerek\u00e7elendirildi\u011finde risk tabanl\u0131 protokoller (BSL-2+) uygulayabilirler mi? Kalite y\u00f6netim sistemleri sa\u011flam ve denetime haz\u0131r olmal\u0131, ruhsatland\u0131rma ba\u015fvurular\u0131 i\u00e7in veri b\u00fct\u00fcnl\u00fc\u011f\u00fc sa\u011flamal\u0131d\u0131r.<\/p>\n<h3 id=\"evaluatingstrategicpositionandsupplychain\">Stratejik Konum ve Tedarik Zincirinin De\u011ferlendirilmesi<\/h3>\n<p>Bir orta\u011f\u0131n ulusal veya uluslararas\u0131 biyog\u00fcvenlik a\u011flar\u0131 i\u00e7indeki rol\u00fc, kapasite ve g\u00fcvenilirli\u011fin g\u00fc\u00e7l\u00fc bir g\u00f6stergesidir. Ulusal bir BSL-3\/4 a\u011f\u0131na \u00fcyelik genellikle yedek kapasiteye eri\u015fim, payla\u015f\u0131lan uzmanl\u0131k ve en y\u00fcksek standartlara ba\u011fl\u0131l\u0131k anlam\u0131na gelir. T\u00fcm sarf malzemeleri ve ekipmanlar i\u00e7in tedarik zinciri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc inceleyin. Muhafazaya giren her \u00f6\u011fenin kayna\u011f\u0131n\u0131 ve sertifikasyonunu garanti edemeyen bir ortak, ara\u015ft\u0131rma zaman \u00e7izelgenize ve g\u00fcvenlik g\u00fcvencenize savunulamaz bir de\u011fi\u015fken ekler.<\/p>\n<table>\n<thead>\n<tr>\n<th>De\u011ferlendirme Kriterleri<\/th>\n<th>Temel G\u00f6sterge \/ Gereksinim<\/th>\n<th>Gerek\u00e7e<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Patojen ve Model Deneyimi<\/td>\n<td>Spesifik ajan ve hayvan modeli uzmanl\u0131\u011f\u0131<\/td>\n<td>\u0130lgili, onaylanm\u0131\u015f \u00e7al\u0131\u015fma tasar\u0131m\u0131 sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>Operasyonel Esneklik<\/td>\n<td>BSL-2+ \/ BSL-3+ adaptasyon kabiliyeti<\/td>\n<td>Risk i\u00e7in kaynak kullan\u0131m\u0131n\u0131 optimize eder<\/td>\n<\/tr>\n<tr>\n<td>Kalite Y\u00f6netimi<\/td>\n<td>Sa\u011flam, denetime haz\u0131r sistemler<\/td>\n<td>Veri b\u00fct\u00fcnl\u00fc\u011f\u00fc ve mevzuat g\u00fcveni sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>A\u011f Pozisyonu<\/td>\n<td>Ulusal BSL-3\/4 a\u011f \u00fcyesi<\/td>\n<td>A\u015f\u0131r\u0131 kapasite ve derin uzmanl\u0131\u011f\u0131 g\u00f6sterir<\/td>\n<\/tr>\n<tr>\n<td>Tedarik Zinciri B\u00fct\u00fcnl\u00fc\u011f\u00fc<\/td>\n<td>BSL-3 sertifikal\u0131 sarf malzemeleri<\/td>\n<td>Muhafaza b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc korur<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Kaynak: <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240011311\">DS\u00d6 Laboratuvar Biyog\u00fcvenlik El Kitab\u0131, D\u00f6rd\u00fcnc\u00fc Bask\u0131<\/a>. K\u0131lavuz, biyog\u00fcvenlik konusunda risk temelli bir yakla\u015f\u0131m\u0131 te\u015fvik etmekte ve sadece sertifikasyon yerine belirli risk de\u011ferlendirmelerine, kan\u0131tlanm\u0131\u015f yetkinli\u011fe ve sa\u011flam y\u00f6netim sistemlerine dayal\u0131 ortak de\u011ferlendirmesine duyulan ihtiyac\u0131n alt\u0131n\u0131 \u00e7izmektedir.<\/em><\/p>\n<p>Bir ABSL-3 tesisini in\u015fa etme, i\u015fbirli\u011fi yapma veya d\u0131\u015f kaynak kullanma karar\u0131 \u00fc\u00e7 \u00f6nceli\u011fe ba\u011fl\u0131d\u0131r: teknik \u00f6zellikleri kesin ara\u015ft\u0131rma ihtiya\u00e7lar\u0131yla uyumlu hale getirmek, titiz bir do\u011frulama ve e\u011fitim k\u00fclt\u00fcr\u00fc uygulamak ve temel sertifikasyonun \u00f6tesinde yetkinli\u011fi kan\u0131tlanm\u0131\u015f ortaklar se\u00e7mek. Bu tesislerin finansal ve operasyonel a\u011f\u0131rl\u0131\u011f\u0131, sadece taktiksel de\u011fil stratejik bir yakla\u015f\u0131m gerektirmektedir.<\/p>\n<p>Bu karma\u015f\u0131k ortamda gezinmek, biyog\u00fcvenli\u011fin \u00e7\u0131\u011f\u0131r a\u00e7an ara\u015ft\u0131rmalar i\u00e7in bir engel de\u011fil, temel oldu\u011funu anlayan bir ortak gerektirir. Bula\u015f\u0131c\u0131 hastal\u0131k boru hatt\u0131n\u0131za y\u00fcksek konteynerli ara\u015ft\u0131rmalar\u0131 entegre etme konusunda profesyonel rehberli\u011fe mi ihtiyac\u0131n\u0131z var? \u00d6zel \u00e7\u00f6z\u00fcmleri ve dan\u0131\u015fmanl\u0131k yakla\u015f\u0131m\u0131n\u0131 \u015fu adreste ke\u015ffedin <a href=\"https:\/\/qualia-bio.com\/tr\/\">QUALIA<\/a>.<\/p>\n<h2 id=\"frequentlyaskedquestions\">S\u0131k\u00e7a Sorulan Sorular<\/h2>\n<p><strong>S: Standart bir BSL-3 ile bir ABSL-3 tesisi aras\u0131ndaki kritik tasar\u0131m farklar\u0131 nelerdir?<\/strong><br \/>\nC: Birincil fark, enfekte hayvanlar\u0131n bar\u0131nd\u0131r\u0131lmas\u0131 i\u00e7in \u00f6zel altyap\u0131n\u0131n entegrasyonudur ve bu da benzersiz m\u00fchendislik zorluklar\u0131n\u0131 beraberinde getirir. Bir ABSL-3 laboratuvar\u0131, hayvan ta\u015f\u0131ma ve nekropsi i\u00e7in titiz protokollerin yan\u0131 s\u0131ra \u0131s\u0131, nem ve aerosolleri y\u00f6netmek i\u00e7in Bireysel Havaland\u0131rmal\u0131 Kafes (IVC) sistemleri gibi geli\u015fmi\u015f kafesleme gerektirir. Bu da, standart bir BSL-3 laboratuvar\u0131 canl\u0131 deneklerin getirdi\u011fi de\u011fi\u015fkenleri g\u00fcvenli bir \u015fekilde bar\u0131nd\u0131ramayaca\u011f\u0131ndan, in vivo meydan okuma \u00e7al\u0131\u015fmalar\u0131n\u0131 i\u00e7eren ara\u015ft\u0131rma programlar\u0131n\u0131n bu geli\u015fmi\u015f muhafaza \u00f6zellikleri i\u00e7in b\u00fct\u00e7e ay\u0131rmas\u0131 gerekti\u011fi anlam\u0131na gelir.<\/p>\n<p><strong>S: Bir ABSL-3 tesisi i\u00e7in s\u00fcrekli uyumlulu\u011fu nas\u0131l do\u011fruluyor ve s\u00fcrd\u00fcr\u00fcyorsunuz?<\/strong><br \/>\nC: S\u00fcrekli validasyon zorunludur ve HEPA filtrelerinin d\u00fczenli olarak sertifikaland\u0131r\u0131lmas\u0131n\u0131, y\u00f6nl\u00fc hava ak\u0131\u015f\u0131n\u0131n ve negatif bas\u0131n\u00e7 kademelerinin do\u011frulanmas\u0131n\u0131 ve otoklavlar gibi dekontaminasyon ekipmanlar\u0131n\u0131n validasyonunu i\u00e7erir. Yap\u0131land\u0131r\u0131lm\u0131\u015f bir biyorisk y\u00f6netim sisteminin benimsenmesi, \u00f6rne\u011fin <a href=\"https:\/\/www.iso.org\/news\/ref2472.html\">ISO 35001<\/a>, devam eden yetkinli\u011fi g\u00f6stermek i\u00e7in bir \u00e7er\u00e7eve sa\u011flar. Uzun vadeli farmas\u00f6tik \u00e7al\u0131\u015fmalar i\u00e7in, bu yinelenen do\u011frulama program\u0131n\u0131 ve ilgili maliyetlerini planlaman\u0131z gerekir, \u00e7\u00fcnk\u00fc bu, y\u0131k\u0131c\u0131 muhafaza ar\u0131zas\u0131n\u0131 ve projeyi geciktiren aksama s\u00fcrelerini \u00f6nlemek i\u00e7in gereklidir.<\/p>\n<p><strong>S: Bir ABSL-3 laboratuvar\u0131 kurmak ve i\u015fletmek i\u00e7in ba\u015fl\u0131ca maliyet etkenleri nelerdir?<\/strong><br \/>\nC: Sermaye yat\u0131r\u0131m\u0131, s\u0131zd\u0131rmaz in\u015faat, HEPA filtrasyonlu \u00f6zel HVAC ve kilitli eri\u015fim sistemleri i\u00e7in s\u0131k\u0131 altyap\u0131 taraf\u0131ndan domine edilmektedir. Sermaye yat\u0131r\u0131m\u0131n\u0131 korumak i\u00e7in ilk in\u015fa maliyetinin 10-15%'si olarak tahmin edilen y\u0131ll\u0131k bak\u0131m ile operasyonel giderler de \u00f6nemlidir. Bu yinelenen maliyet modeli, daha k\u00fc\u00e7\u00fck kurulu\u015flar i\u00e7in d\u0131\u015f kaynak kullan\u0131m\u0131n\u0131 g\u00fc\u00e7l\u00fc bir \u015fekilde desteklerken, b\u00fcy\u00fck kurulu\u015flar bu y\u00fcksek i\u015fletme maliyetlerini uzun vadeli program b\u00fct\u00e7elerine entegre etmelidir.<\/p>\n<p><strong>S: ABSL-3 i\u015fi i\u00e7in bir d\u0131\u015f kaynak i\u015f orta\u011f\u0131 se\u00e7erken hangi kriterleri kullanmal\u0131y\u0131z?<\/strong><br \/>\nC: Orta\u011f\u0131n patojen ve hayvan modelinizle ilgili \u00f6zel deneyimini, riske dayal\u0131 uyarlamalar i\u00e7in operasyonel esnekli\u011fini ve sa\u011flam kalite y\u00f6netim sistemlerini de\u011ferlendirmek i\u00e7in temel sertifikasyonun \u00f6tesine bak\u0131n. Ulusal biyog\u00fcvenlik a\u011flar\u0131 i\u00e7indeki rolleri ve t\u00fcm sarf malzemeleri i\u00e7in tedarik zincirlerinin b\u00fct\u00fcnl\u00fc\u011f\u00fc de \u00e7ok \u00f6nemli g\u00f6stergelerdir. Bu, se\u00e7im s\u00fcrecinizin, giri\u015fin \u00f6n\u00fcndeki y\u00fcksek engelleri a\u015fmak i\u00e7in \u015feffaf, denetime haz\u0131r s\u00fcre\u00e7ler sa\u011flayarak bir g\u00fc\u00e7 \u00e7arpan\u0131 olarak hareket edebilecek ortaklara \u00f6ncelik vermesi gerekti\u011fi anlam\u0131na gelir.<\/p>\n<p><strong>S: ABSL-3 ortam\u0131nda hayvanlar\u0131n varl\u0131\u011f\u0131 operasyonel protokolleri nas\u0131l de\u011fi\u015ftiriyor?<\/strong><br \/>\nC: Hayvan \u00e7al\u0131\u015fmas\u0131, bir biyog\u00fcvenlik kabini i\u00e7inde ger\u00e7ekle\u015fmesi gereken t\u00fcm aerosol \u00fcreten prosed\u00fcrler i\u00e7in kapsaml\u0131 protokolleri zorunlu k\u0131lar ve kapal\u0131 santrif\u00fcj rotorlar\u0131n\u0131n kullan\u0131lmas\u0131n\u0131 gerektirir. Personel, solunum korumas\u0131 (N95 veya PAPR'ler) dahil olmak \u00fczere tam KKD giymeli ve bir t\u0131bbi g\u00f6zetim program\u0131na kat\u0131lmal\u0131d\u0131r. Ekibiniz i\u00e7in bu, eri\u015fimden \u00f6nce zorunlu, \u00f6zel e\u011fitim ve y\u0131ll\u0131k tazeleme anlam\u0131na gelir ve personel yetkinli\u011fini g\u00fcvenli zoonotik terap\u00f6tik geli\u015ftirme i\u00e7in pazarl\u0131k konusu olmayan bir kolayla\u015ft\u0131r\u0131c\u0131 haline getirir.<\/p>\n<p><strong>S: Bir hayvan BSL-3 farmas\u00f6tik tesisi i\u00e7in hava temizli\u011fi s\u0131n\u0131fland\u0131rmas\u0131 neden \u00f6nemlidir?<\/strong><br \/>\nC: Uygun hava s\u0131n\u0131fland\u0131rmas\u0131, \u00fcr\u00fcnlerin i\u015flendi\u011fi veya hayvanlar\u0131n bar\u0131nd\u0131r\u0131ld\u0131\u011f\u0131 alanlarda kontaminasyon kontrol\u00fc i\u00e7in temeldir ve veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc ve hayvan refah\u0131n\u0131 do\u011frudan destekler. A\u015fa\u011f\u0131daki gibi standartlar <a href=\"https:\/\/www.iso.org\/obp\/ui\/en\/#!iso:std:88599:en\">ISO 14644-1<\/a> bu kontroll\u00fc ortamlar\u0131n tasarlanmas\u0131 ve izlenmesi i\u00e7in temel sa\u011flar. Bu, tesis tasar\u0131m\u0131n\u0131z\u0131n partik\u00fcl konsantrasyonu hedeflerini biyog\u00fcvenlik hava ak\u0131\u015f\u0131 gereklilikleri ile entegre etmesi gerekti\u011fi anlam\u0131na gelir. <a href=\"https:\/\/www.cdc.gov\/labs\/pdf\/SF__19_308133-A_BMBL6_00-BOOK-WEB-final-3.pdf\">Mikrobiyolojik ve Biyomedikal Laboratuvarlarda Biyog\u00fcvenlik (BMBL)<\/a> hem g\u00fcvenli\u011fi hem de s\u00fcre\u00e7 b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc sa\u011flamak i\u00e7in.<\/p>\n<p><strong>S: Kaynaklar\u0131 optimize etmek i\u00e7in y\u00fcksek muhafazal\u0131 bir ABSL-3 laboratuvar\u0131nda daha d\u00fc\u015f\u00fck riskli i\u015fler ger\u00e7ekle\u015ftirebilir miyiz?<\/strong><br \/>\nC: Evet, muhafaza seviyesi g\u00f6reve ba\u011fl\u0131d\u0131r ve kurulu\u015flar y\u00fcksek muhafaza alan\u0131n\u0131 verimli bir \u015fekilde kullanmak i\u00e7in riske dayal\u0131 de\u011ferlendirmeler uygulayabilir. \u00d6rne\u011fin, baz\u0131lar\u0131 geli\u015fmi\u015f KKD ve prosed\u00fcrler kullanarak d\u00fc\u015f\u00fck konsantrasyonlu \u00e7al\u0131\u015fmalar i\u00e7in BSL-2 laboratuvarlar\u0131n\u0131 \u201cBSL-2+\u201dya d\u00f6n\u00fc\u015ft\u00fcrmektedir. Bu operasyonel esneklik, k\u0131t kaynaklar\u0131 y\u00f6netmek i\u00e7in kritik bir kald\u0131ra\u00e7t\u0131r, ancak a\u015fa\u011f\u0131daki raporda tavsiye edildi\u011fi gibi olgun bir risk de\u011ferlendirme \u00e7er\u00e7evesi gerektirir <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240011311\">DS\u00d6 Laboratuvar Biyog\u00fcvenlik K\u0131lavuzu<\/a>, g\u00fcvenli\u011fin asla tehlikeye at\u0131lmamas\u0131n\u0131 sa\u011flamak i\u00e7in.<\/p>","protected":false},"excerpt":{"rendered":"<p>Ticari ama\u00e7l\u0131 BSL-3 hayvan laboratuvarlar\u0131n\u0131n, ila\u00e7 end\u00fcstrisi i\u00e7in ileri d\u00fczey veterinerlik ve bula\u015f\u0131c\u0131 hastal\u0131k ara\u015ft\u0131rmalar\u0131n\u0131 nas\u0131l m\u00fcmk\u00fcn k\u0131ld\u0131\u011f\u0131n\u0131 inceleyin. Temel yetkinlikleri ve stratejik avantajlar\u0131 ke\u015ffedin.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"n8n_meta_description":"","footnotes":""},"categories":[21],"tags":[],"class_list":["post-7072","post","type-post","status-publish","format-standard","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts\/7072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/comments?post=7072"}],"version-history":[{"count":1,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts\/7072\/revisions"}],"predecessor-version":[{"id":7073,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts\/7072\/revisions\/7073"}],"wp:attachment":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/media?parent=7072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/categories?post=7072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/tags?post=7072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}